Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextenza vs Topical Steroid Eye Drops for Postoperative Management of Corneal Collagen Crosslinking
NCT06235567Phase 2Enrolling by invitation
- Start
- Apr 2025
- Primary completion
- Dec 2026
- Modality
- Implantable Devices, Implantable Hydrogels, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of dexamethasone in post-operative inflammation (2 arms). Primary endpoints: Corneal haze at 1 month, Corneal re-epithelialization at 6 months and 2 more. Started Apr 2025; status: enrolling by invitation.
02
Drugs
dexamethasone
03
Conditions
post-operative inflammation
Beyond the preview
Go deeper on NCT06235567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06235567.